Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema

INTRODUCTION: Diabetic retinopathy is the most common cause of visual loss and blindness in the age group of 20 to 64 years. This study aimed to evaluate the efficacy of oral Losartan adjuvant therapy in combination with intravitreal injection of Bevacizumab in the treatment of diabetic macular edem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghassemi, Fariba, Amini, Abdulrahim, Yasemi, Masoud, Nabavi, Amin, Johari, Mohammadkarim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547354/
https://www.ncbi.nlm.nih.gov/pubmed/33062311
http://dx.doi.org/10.1155/2020/4528491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547354/
https://www.ncbi.nlm.nih.gov/pubmed/33062311
http://dx.doi.org/10.1155/2020/4528491

Ejemplares similares